Refining letermovir prophylaxis strategies and CD4 + T cell-guided discontinuation in aplastic anemia patients post-allogeneic HSCT: a retrospective analysis.

Despite some variations in conditioning regimens and donor characteristics, these differences did not reach statistical significance, indicating overall comparability across the study groups (Table 1 ).

also in 75,281 other papers

In our study, the incidence of grade II–IV aGVHD was numerically lower in patients who received letermovir prophylaxis than in those who did not; however, this difference did not reach statistical significance and should be interpreted only as a possible trend rather than firm evidence of a protective effect.

also in 939 other papers